Journalist Hunt

JournalistsPricingBlogs
LoginSign up

Gerd R Burmester - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Gerd R Burmester's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Gerd R Burmester

Gerd R Burmester

Verified

Contributor, Annals of the Rheumatic Diseases

Berlin

Beats

Primary beats

Health

Secondary beats

World NewsCigarsWellnessForeign NewsNewsPersonal EssayMemoirBusinessNutritionCareerCatsSocial TrendsDoctorsCity GuidesInteriors

Final Covers

Doesn’t Cover

Gambling, Adult Content

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 61

  • Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)

    By Gerd R Burmester, John R.P. Tesser, Anna Shmagel, Yanxi Liu

    Jul. 01, 2024

  • Upadacitinib’s risk-benefit profile in rheumatoid arthritis ‘favorable’ through 5 years

    By Justin Cooper, Shenaz Bagha Verified, Gerd R Burmester

    Jun. 27, 2024

  • Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)

    By Gerd R Burmester, John R.P. Tesser, Anna Shmagel, Yanxi Liu

    Jul. 01, 2024

As seen in

Arthritis Research & Therapy,The Journal Of Rheumatology,Annals Of The Rheumatic Diseases,Healio Rheumatology,Healio,The Lancet,Bmj Open

Company Info

Annals of the Rheumatic Diseases

Berlin, Berlin, Germany

+49 30 45050

Founded: